Smiths Medical ASD, Inc. is recalling 185,975 CADD-Solis HPCA and CADD-Solis VIP Ambulatory Infusion Pumps because they may trigger false 'Upstream Occlusion' alarms. These erroneous alarms stop the delivery of medication to the patient, which is dangerous if the patient depends on a continuous flow of therapy. The recall affects a wide range of model numbers and catalog codes used in hospitals and home care settings worldwide.
The infusion pump may incorrectly detect a blockage in the tubing and stop delivering medication. This interruption or delay in critical therapy can lead to serious patient injury or death, especially for patients requiring life-sustaining infusions.
Includes Clinical Evaluation and Demo pumps.
Includes standard and loaner pumps in multiple software versions.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.